The market continues to stay in a tight range, following a four-week rally that pushed the major stock benchmarks to new record highs. Investors are waiting for Nvidia to report its earnings, with analysts expecting bigger things from the artificial intelligence chip powerhouse. Updates on Nvidia’s next-generation Blackwell chip platform and software business will be key watch items. Activist investor group Eminence Capital has built a stake in Reckitt Benckiser, following concerns about baby formula litigation. Abbott Labs, another Club name, has also been weighed down by baby formula lawsuits. Despite this, investors are slowly building up their position in these companies into weakness, as they believe the market has overreacted to the litigation risks. Abbott’s exposure is believed to be much less than what its stock has been penalized for, and the medical community is supportive of the company.
After the closing bell, homebuilder Toll Brothers will report earnings, followed by TJX Companies, Target, Analog Devices, and Williams-Sonoma on Wednesday. Subscribers to the CNBC Investing Club with Jim Cramer will receive a trade alert before Jim makes a trade, with a waiting period before executing the trade to ensure compliance with trading regulations. The Investing Club information is subject to terms and conditions, privacy policy, and disclaimer, and no specific outcome or profit is guaranteed. The market continues to stay in a tight range, following a four-week rally that pushed the major stock benchmarks to new record highs. Investors are waiting for Nvidia to report its earnings, with analysts expecting bigger things from the artificial intelligence chip powerhouse. Updates on Nvidia’s next-generation Blackwell chip platform and software business will be key watch items. Activist investor group Eminence Capital has built a stake in Reckitt Benckiser, following concerns about baby formula litigation. Abbott Labs, another Club name, has also been weighed down by baby formula lawsuits. Despite this, investors are slowly building up their position in these companies into weakness, as they believe the market has overreacted to the litigation risks. Abbott’s exposure is believed to be much less than what its stock has been penalized for, and the medical community is supportive of the company.
After the closing bell, homebuilder Toll Brothers will report earnings, followed by TJX Companies, Target, Analog Devices, and Williams-Sonoma on Wednesday. Subscribers to the CNBC Investing Club with Jim Cramer will receive a trade alert before Jim makes a trade, with a waiting period before executing the trade to ensure compliance with trading regulations. The Investing Club information is subject to terms and conditions, privacy policy, and disclaimer, and no specific outcome or profit is guaranteed.
